GW PHARMACEUTICALS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
GW PHARMACEUTICALS PLC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $7.92 per share as of 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2021-02-26
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $7.92.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $4.99.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $6.90.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.74.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2020-12-31 | $7.92 10-K · filed 2021-02-26 |
| 2019-12-31 | $4.99 10-K · filed 2021-02-26 |
| 2018-12-31 | $6.90 10-K · filed 2021-02-26 |
| 2018-09-30 | $8.74 10-K · filed 2021-02-26 |
| 2016-09-30 | $1.17 10-KT · filed 2019-02-28 |